Shigellosis
Infectious Disease·MeSH: Dysentery, Bacillary
Prevalence
5.0 / 100K
2 drugs in development·2 companies·1 clinical trial
Drug Pipeline by Phase
Phase 1(1)
Preclinical(1)
| Drug | Company |
|---|---|
| vax-gi | Vaxcyte, Inc. (PCVX) |
Compare drugs
Frequently asked questions
How many drugs are in development for Shigellosis?
BioSniper tracks 2 drugs in development for Shigellosis across 2 companies.
How many clinical trials target Shigellosis?
There are 1 clinical trial targeting Shigellosis tracked by BioSniper.
What is the prevalence of Shigellosis?
The estimated prevalence of Shigellosis is approximately 5.0 per 100,000 population.
Deep-dive into Shigellosis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis